Hipertension arterial. Revision bibliografica
Autor: Dra. Yenys Góngora Ruiz | Publicado:  14/09/2009 | Cardiologia , Nefrologia , Medicina Interna , Medicina Familiar y Atencion Primaria | |
Hipertension arterial. Revision bibliografica.6


 

17. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension. Circulation 1998;98:1892-97.

18. Strandberg TE, Saloona V. White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J 2000;21:1715–19.

19. Kincaid-Smith P. Malignant Hypertension. J Hypertens 1991;9:893-99.

20. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The 1980 Report. Arch Intern Med 1980;140:1280–85.

21. Veterans Administration (VA) Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 1967;202:1028-34.

22. Veterans Administration (VA) Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-52.

23. Smith Jr SC, Greenland P, Grundy SM. Prevention Conference V. Beyond Secondary Prevention: identifying the high-risk patient for Primary Prevention. Executive Summary. Circulation 2000;101:111-16.

24. Deveraux R, Pickering TG, Harshfiel GA, et al: Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regulatory recurrent stress. Circulation 1983;68:470–76.

25. Rocco MB, Nabel EG, Selwyn AP: Circadian rhythm and coronary artery disease. Am J Cardiol 1987;59:13C-17C.

26. White WB, Dey HM, Schulman P: Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild to moderate hypertension. Am Heart J 1989;118:782-85.

27. Verdecchia P, Schillaci G, Guerrieri M, et al: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.

28. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variation and silent cerebrovascular damage in elderly patients with hypertension. J Hyperten 1992;10:875–78.

29. Frattola A, Parati G, Cuspidi C, et al: Prognostic value of 24-hour blood pressure variability. J Hypertens 1993;11:1133–37.

30. Parati G, Ravogli A, Frattola A, et al. Blood pressure variability: clinical implications and effects of antihypertensive treatment. J Hypertens 1994;12(Suppl 5):S35–S40.

31. Coca A. Variabilidad de la presión arterial, protección de órganos blanco y control de la presión en 24 horas. Arch Hosp Vargas 1998;40:17–21.

32. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995;13:1105–12.

33. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eherlein K, Godwin J et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-38.

34. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 355:1955-64. Keeley FW, Elmoselhi A, Leenen FHH: Effects of antihypertensive drug class on regression of connective tissue components of hypertension. J Cardiovasc Pharmacol 1991;17(Suppl 2):S64-S69.

35. Domínguez P. Epidemiología de las enfermedades cardiovasculares. Temario especial, Temas Divulgativos 2002. Disponible en URL: http:// coresalud. com/.htm.

36. Coca A. De la Sierra A. Ingesta de café. En su esquema de diagnóstico y tratamiento del paciente hipertenso. Barcelona. Editorial Médica. JIMS; 1998: 55 -5.

37. Jiménez DC. ¿Estamos controlando el factor de riesgo “Hipertensión Arterial “en la población hipertensa de nuestro centro de salud?. Hipertensión 1999; 16 (9): 332 -36.

38. Mashour NH, Lin Gi, Frisham wh. Herbal. Medicina para el tratamiento de las enfermedades cardiovasculares: Consideraciones clínicas. Archivo interno Med. 2000, 158 (20): 225 -34.

39. Hipertensión Arterial. En su: Roca. Temas de Medicina Interna. 3 ed. La Habana. Editorial Pueblo y Educación; 1998. T1: 215 -236.

40. Badimón JJ, Fuster V, Chesebro JH, Badimón L. Coronary Atherosclerosis: A multifactorial disease. Circulation 1993; 87: II-3-II-16.

41. Fuster V, Badimón. Badimón JJ, L Chesebro JH. The patogénesis of coronary artery disease and the acute coronary síndromes (part I) New Engl J Med 1992; 326:242-250.

42. Ishihara M, Inoue I. Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Impact of spontaneous anterograde flor of the infarct artery on left ventricular function in patients with a first anterior wall acute myocardial infarction. Am J Cardiol. 2002; 90(I):5-9.

43. Kanuel WB. Practice an sistoli hipertention: The Framingham study circulation. 1980; 61:1179 _82.

44. Shorteff D. Sectron 30. Some characteristic to the incidence of cardiovascular disease and death. Framingham study 18 years fallow up. Dhew publication (NYH) 2001; 74 – 599.

45. Gebara OC, et al. Association between increased fibrinolytic potential in the Framingham of spring study. Circulation 1995, 91: 1952 – 58.

46. The V report of the joint National committe on detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1997: 157: 2415 -46.

47. Mashour NH, Lin Gi, Frisham wh. Herbal. Medicina para el tratamiento de las enfermedades cardiovasculares: Consideraciones clínicas. Archivo interno Med. 1998, 158 (20): 225 -34.


Revista Electronica de PortalesMedicos.com
INICIO - NOVEDADES - ÚLTIMO NÚMERO - ESPECIALIDADES - INFORMACIÓN AUTORES
© PortalesMedicos, S.L.
PortadaAcerca deAviso LegalPolítica de PrivacidadCookiesPublicidadContactar